Antihistamines for Perimenopause Symptoms

Before going through perimenopause, Angela was hiking over 100 miles each month. She felt quite active, even relocating to the mountains to pursue her passion for hiking. But then, perimenopause hit her hard. “Man, oh man,” she reflects, “it wiped me out.”

After consulting her doctor, Angela began hormone replacement therapy (HRT) for her symptoms, but it didn’t provide the relief she hoped for. Fatigue lingered, and she found herself disinterested in hiking and other hobbies she once loved. A few months back, she stumbled across a social media post about a woman who used daily antihistamines—like Allegra, Claritin, and Zyrtec—along with Pepcid AC to combat her perimenopause symptoms. The results sounded almost miraculous: no more brain fog or sleepless nights, and a significant mood lift.

Now 55, Angela decided to give this regimen a try. As a former neuroscientist turned data scientist, she understood the potential reasons behind the efficacy of these over-the-counter medications. She knew that hormonal changes might trigger inflammation, which antihistamines could help to alleviate. Angela has shared her findings and research on Threads, where numerous posts discussing these medications have gained traction recently.

While the current online discussions primarily focus on antihistamines for perimenopause or PMDD symptoms—conditions that sometimes overlap—these medications have also attracted attention from those suffering from various chronic illnesses, including mast cell activation syndrome (MCAS), long COVID, and post-orthostatic tachycardia syndrome (POTS).

Zachary Rubin, an allergist and clinical immunologist, notes that he has encountered patients using antihistamines for years. “Women approach their doctors saying, ‘I take Allegra and Pepcid, and my PMDD symptoms go away. It feels like magic,’” he mentioned during a phone conversation from his office in Chicago. Following a recent interview about the medication combo with OB/GYN and menopause specialist Mary Claire Haver, he has noticed an uptick in inquiries about this method. However, he cautions that so far, these anecdotal experiences lack clinical backing. “No clinical trials verify this information,” he asserts, although he doesn’t dismiss the possibility that they could be effective for some individuals.

Rubin goes on to explain that some research suggests a possible dysregulation of histamine during the luteal phase of the menstrual cycle, which often corresponds with PMDD symptoms. Given that histamine also influences sleep, mood, digestion, and pain signaling—all aspects that may become unbalanced during hormonal changes—it seems reasonable that antihistamines could offer relief.

Lisa Mosconi, a neuroscientist and author, agrees with this perspective. She explains that fluctuations in ovarian hormones can affect immune function and mast-cell signaling. This so-called “blockade” by antihistamines might help mitigate those effects.

For Henry, a 30-year-old writer, these medications have significantly eased his symptoms. After developing long COVID and subsequently POTS, he was often told by doctors that his issues stemmed from being overweight. “For a year, I felt strange and unwell,” he recalls. After seeing Pepcid recommended on TikTok for PMS, he started taking it and noticed almost immediate relief from mood swings and brain fog.

Henry discussed his approach with a new psychiatric nurse practitioner who was familiar with chronic illnesses and mental health. He also asked about taking Allegra for allergies; she encouraged him, having heard of its combined benefits with Pepcid for long COVID and POTS. He has been using both for a year—daily Allegra and Pepcid during the ten days leading up to his cycle. “I’m cautious about taking Pepcid every day since I’m uncertain about long-term effects,” he points out. Nonetheless, he has seen significant improvement in symptoms like brain fog and malaise since starting this routine.

Sibyl, a 49-year-old consultant, has also turned to daily Zyrtec and Pepcid after discovering it online. For her, it has brought considerable relief from joint pain—a symptom worsened by her lifelong hypermobility. Despite being in physical therapy and taking Celebrex for pain, she experienced “overnight relief” with these antihistamines. “I took it one night and woke up shocked the next day,” she shares. She attributes part of her relief to improved sleep, as Zyrtec can induce drowsiness, and she’s now sleeping through the night for the first time in ages.

When Sibyl shared her results with her physical therapist and OB/GYN, they were supportive. She plans to consult her allergist next. “I’ll get a consensus on this, but I’m still taking it since it works,” she says. Unexpected benefits have accompanied these medications; she’s found that they have diminished her tinnitus—ringing in her ears from a past ear infection—more than any other treatment.

Rubin highlights that the variations in routines among those using antihistamines for unapproved uses highlight the need for clinical trials. “We still really need research to determine effective dosages,” he explains. He adds that while these medications are generally considered safe due to their over-the-counter status, they do carry some risks.

“Allegra is seen as quite safe, but stopping it suddenly can cause issues like weight gain or itching,” he notes. “As for Pepcid, while long-term concerns are uncommon, it could affect nutrient absorption, especially for vitamins B-12, magnesium, and calcium.” He emphasizes caution for individuals with kidney issues, as long-term use of Pepcid may worsen side effects.

Experts caution that anyone considering this medication combo should consult their healthcare provider, particularly when it pertains to off-label uses affecting mood and cognition. “We don’t want to overlook any underlying conditions that could explain these symptoms,” Rubin affirms. For perimenopause, Mosconi mentions that there are indeed more evidence-based treatments available.

However, she acknowledges the frustration women face with limited research and treatment options. “Women’s midlife health has faced chronic underfunding, and these are low-cost, generic medications that lack commercial incentive for large studies,” she explains. “Compounding that is the challenge of studying cyclical symptoms and varying presentations, leading to a situation where personal anecdotes spread quicker than science, although those are precisely the topics that warrant rigorous testing.”

Rubin is hopeful that the recent attention to these medications’ off-label uses might prompt more research, though he remains somewhat skeptical. “As healthcare becomes more corporate and trust in the system declines, people will inevitably seek out alternatives,” he notes. “Many adults are now turning to online sources for health information. Social media’s strength lies in storytelling and individuals sharing their experiences.”

Sibyl reflects on the overwhelming response to her Threads post, recognizing the frustration many share. “I saw someone else mention that it feels like every woman over 35 is participating in a drug trial from their living room, and that does seem to be the case,” she observes. “The standard response at doctors’ offices often seems to be, ‘Lose weight; you’re fat and anxious,’ leaving so many of us feeling dismissed.”